PGNX / Progenics Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Progenics Pharmaceuticals, Inc.
US ˙ NASDAQ ˙ US7431871067
DENNA SYMBOL ÄR INTE LÄNGRE AKTIV

Insideraktier19 054 832 shares
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

N/A

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

N/A

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

Progenics Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PGNX / Progenics Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2019-09-09 LTE Partners, LLC 21 480 4,9393 21 480 4,9393 106 096 60
2019-09-09 Velan Capital, L.P. 72 023 4,9947 72 023 4,9947 359 733
2019-09-05 LTE Partners, LLC 43 520 4,6208 43 520 4,6208 201 097
2019-09-04 Velan Capital, L.P. 243 614 4,5093 243 614 4,5093 1 098 529
2019-09-03 Velan Capital, L.P. 277 424 4,3937 277 424 4,3937 1 218 918
2019-08-26 Velan Capital, L.P. 73 230 4,3003 73 230 4,3003 314 911
2019-08-23 Velan Capital, L.P. 130 826 4,3087 130 826 4,3087 563 690
2014-07-21 Broadfin Healthcare Master Fund Ltd 388 659 4,7300 388 659 4,7300 1 838 357
2014-07-18 Broadfin Healthcare Master Fund Ltd 388 200 4,7300 388 200 4,7300 1 836 186

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

PGNX / Progenics Pharmaceuticals, Inc. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PGNX / Progenics Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2017-02-15 Broadfin Healthcare Master Fund Ltd 150 000 9,5500 150 000 9,5500 1 432 500 355
2017-02-14 Broadfin Healthcare Master Fund Ltd 150 000 9,6800 150 000 9,6800 1 452 000
2017-02-14 Broadfin Healthcare Master Fund Ltd 100 000 9,7000 100 000 9,7000 970 000
2017-02-14 Broadfin Healthcare Master Fund Ltd 50 000 9,7000 50 000 9,7000 485 000
2017-02-14 Broadfin Healthcare Master Fund Ltd 52 600 9,7000 52 600 9,7000 510 220
2017-02-13 Broadfin Healthcare Master Fund Ltd 100 000 9,7000 100 000 9,7000 970 000
2017-02-09 Broadfin Healthcare Master Fund Ltd 100 000 9,6600 100 000 9,6600 966 000
2017-02-09 Broadfin Healthcare Master Fund Ltd 100 000 9,7500 100 000 9,7500 975 000
2017-02-09 Broadfin Healthcare Master Fund Ltd 1 300 9,6850 1 300 9,6850 12 590

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

PGNX / Progenics Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2020-06-23 2020-06-19 4 Maeusli Heinz Christoph PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 −16 393 0
2020-06-23 2020-06-19 4 Maeusli Heinz Christoph PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 −40 000 0
2020-06-23 2020-06-19 4 MacDougall Ann L. PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 −36 065 0
2020-06-23 2020-06-19 4 MacDougall Ann L. PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 −40 000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,74 −25 000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 8,99 −25 000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,47 −20 000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,95 −20 000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,89 −20 000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,72 −20 000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,50 −40 000 0
2020-06-23 2020-06-19 4 Ende Eric J PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 −16 393 0
2020-06-23 2020-06-19 4 Ende Eric J PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 −40 000 0
2020-06-23 2020-06-19 4 Campbell Bradley L PGNX Stock Option (Right to Buy) D - Sale to Issuer D 8,99 −25 000 0
2020-06-23 2020-06-19 4 Campbell Bradley L PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,74 −25 000 0
2020-06-23 2020-06-19 4 Campbell Bradley L PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,95 −20 000 0
2020-06-23 2020-06-19 4 Campbell Bradley L PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,89 −28 000 0
2020-06-23 2020-06-19 4 Campbell Bradley L PGNX Common Stock D - Sale to Issuer D −12 000 0
2020-06-23 2020-06-19 4 Ber Gerard PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 −16 393 0
2020-06-23 2020-06-19 4 Ber Gerard PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 −40 000 0
2020-06-23 2020-06-19 4 Ber Gerard PGNX Common Stock D - Sale to Issuer D −50 000 0
2020-06-23 2020-06-19 4 Mims David W. PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 −16 393 0
2020-06-23 2020-06-19 4 Mims David W. PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 −40 000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,77 −82 214 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,52 −90 750 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,62 −94 875 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,52 −82 500 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 11,32 −82 500 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,65 −66 000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,70 −75 000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,70 −52 800 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,03 −48 000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 9,81 −40 000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 7,40 −60 000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,83 −25 000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,35 −6 000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Common Stock D - Sale to Issuer D −4 121 0
2020-06-23 2020-06-19 4 Tenbarge Bryce PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,77 −82 214 0
2020-06-23 2020-06-19 4 Tenbarge Bryce PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,52 −90 750 0
2020-06-23 2020-06-19 4 Tenbarge Bryce PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,62 −75 900 0
2020-06-23 2020-06-19 4 Tenbarge Bryce PGNX Stock Option (Right to Buy) D - Sale to Issuer D 11,32 −66 000 0
2020-06-23 2020-06-19 4 Tenbarge Bryce PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,77 −75 000 0
2020-06-23 2020-06-19 4 Osorio Benedict PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,77 −82 214 0
2020-06-23 2020-06-19 4 Osorio Benedict PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,52 −90 750 0
2020-06-23 2020-06-19 4 Osorio Benedict PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,62 −100 000 0
2020-06-23 2020-06-19 4 Osorio Benedict PGNX Common Stock D - Sale to Issuer D −21 202 0
2020-06-23 2020-06-19 4 Das Asha PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,77 −82 214 0
2020-06-23 2020-06-19 4 Das Asha PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,56 −125 000 0
2020-03-04 2020-03-02 4 Fabbio Patrick PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,77 82 214 82 214
2020-03-04 2020-03-02 4 Tenbarge Bryce PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,77 82 214 82 214
2020-03-04 2020-03-02 4 Wong Vivien PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,77 82 214 82 214
2020-03-04 2020-03-02 4 Osorio Benedict PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,77 82 214 82 214
2020-03-04 2020-03-02 4 Das Asha PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,77 82 214 82 214
2019-12-17 2019-12-13 4 Ber Gerard PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 40 000 40 000
2019-12-17 2019-12-13 4 Ber Gerard PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 16 393 16 393
2019-12-17 2019-12-13 4 Ende Eric J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 40 000 40 000
2019-12-17 2019-12-13 4 Ende Eric J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 16 393 16 393
2019-12-17 2019-12-13 4 MacDougall Ann L. PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 40 000 40 000
2019-12-17 2019-12-13 4 MacDougall Ann L. PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 36 065 36 065
2019-12-17 2019-12-13 4 Mims David W. PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 40 000 40 000
2019-12-17 2019-12-13 4 Mims David W. PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 16 393 16 393
2019-12-17 2019-12-13 4 Maeusli Heinz Christoph PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 40 000 40 000
2019-12-17 2019-12-13 4 Maeusli Heinz Christoph PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 16 393 16 393
2019-09-27 3 Ber Gerard PGNX Common Stock, $0.0013 par value D 100 000
2019-09-27 3 Ber Gerard PGNX Common Stock, $0.0013 par value D 100 000
2019-09-27 3 Ber Gerard PGNX Common Stock, $0.0013 par value D 100 000
2019-09-27 3 Ende Eric J PGNX Common Stock, $0.0013 par value D 0
2019-09-27 3 Maeusli Heinz Christoph PGNX Common Stock, $0.0013 par value D 0
2019-09-27 3 Mims David W. PGNX Common Stock, $0.0013 par value D 0
2019-09-27 3 MacDougall Ann L. PGNX Common Stock, $0.0013 par value D 0
2019-09-11 2019-09-09 4 Velan Capital, L.P. PGNX Common Stock, $0.0013 par value P - Purchase D 4,9947 72 023 360 8 011 733
2019-09-09 2019-09-09 4 LTE Partners, LLC PGNX Common Stock, $0.0013 par value P - Purchase D 4,9393 21 480 106 1 950 000
2019-09-09 2019-09-05 4 LTE Partners, LLC PGNX Common Stock, $0.0013 par value P - Purchase D 4,6208 43 520 201 1 928 520
2019-09-05 2019-09-04 4 Velan Capital, L.P. PGNX Common Stock, $0.0013 par value P - Purchase D 4,5093 243 614 1 099 7 939 710
2019-09-05 2019-09-03 4 Velan Capital, L.P. PGNX Common Stock, $0.0013 par value P - Purchase D 4,3937 277 424 1 219 7 696 096
2019-08-27 3 VENKATARAMAN BALAJI PGNX Common Stock, $0.0013 par value D 14 429 232
2019-08-27 3 VENKATARAMAN BALAJI PGNX Common Stock, $0.0013 par value D 14 429 232
2019-08-27 3 VENKATARAMAN BALAJI PGNX Common Stock, $0.0013 par value D 14 429 232
2019-08-27 3 VENKATARAMAN BALAJI PGNX Common Stock, $0.0013 par value D 14 429 232
2019-08-27 3 VENKATARAMAN BALAJI PGNX Common Stock, $0.0013 par value D 14 429 232
2019-08-27 2019-08-26 4 Velan Capital, L.P. PGNX Common Stock, $0.0013 par value P - Purchase D 4,3003 73 230 315 7 418 672
2019-08-27 2019-08-23 4 Velan Capital, L.P. PGNX Common Stock, $0.0013 par value P - Purchase D 4,3087 130 826 564 7 345 442
2019-08-27 3 Sarpangal Deepak PGNX Common Stock, $0.0013 par value D 0
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3 770 000
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3 770 000
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3 770 000
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3 770 000
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3 770 000
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3 770 000
2019-08-27 3 Nohria Virinder PGNX Common Stock, $0.0013 par value D 220 000
2019-08-27 3 Nohria Virinder PGNX Common Stock, $0.0013 par value D 220 000
2019-08-27 3 Nohria Virinder PGNX Common Stock, $0.0013 par value D 220 000
2019-08-27 3 Cooke Terence PGNX Common Stock, $0.0013 par value D 80 000
2019-08-27 3 Cooke Terence PGNX Common Stock, $0.0013 par value D 80 000
2019-08-27 3 Cooke Terence PGNX Common Stock, $0.0013 par value D 80 000
2019-07-15 2019-07-11 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 25 000 25 000
2019-07-15 2019-07-11 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 25 000 25 000
2019-07-15 2019-07-11 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 25 000 25 000
2019-07-15 2019-07-11 4 Campbell Bradley L PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 25 000 25 000
2019-07-15 2019-07-11 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 55 000 55 000
2019-07-15 2019-07-11 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 25 000 25 000
2019-07-08 2019-07-03 4 Campbell Bradley L PGNX Non-Qualified Stock Option (Right to Buy) M - Exercise D 4,89 −12 000 0
2019-07-08 2019-07-03 4 Campbell Bradley L PGNX Common Stock M - Exercise D 4,8900 12 000 59 12 000
2019-07-03 2019-07-01 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (Right to Buy) M - Exercise D 5,33 −10 000 0
2019-07-03 2019-07-01 4 SCHEINBERG DAVID A PGNX Common Stock M - Exercise D 5,3300 10 000 53 56 185
2019-06-27 2019-06-26 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) M - Exercise D 5,33 −10 000 0
2019-06-27 2019-06-26 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) M - Exercise D 5,35 −40 000 0
2019-06-27 2019-06-26 4 Crowley Peter J PGNX Common Stock M - Exercise D 5,3500 40 000 214 50 000
2019-06-27 2019-06-26 4 Crowley Peter J PGNX Common Stock M - Exercise D 5,3300 10 000 53 10 000
2019-03-05 2019-03-01 4 Osorio Benedict PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,52 90 750 90 750
2019-03-05 2019-03-01 4 Tenbarge Bryce PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,52 90 750 90 750
2019-03-05 2019-03-01 4 Fabbio Patrick PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,52 90 750 90 750
2019-03-05 2019-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,52 192 500 192 500
2019-03-05 2019-03-01 4 Wong Vivien PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,52 90 750 90 750
2019-02-05 2019-02-01 4 Das Asha PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,56 125 000 125 000
2019-01-11 3 Das Asha PGNX Common Stock D 0
2018-06-14 2018-06-13 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 55 000 55 000
2018-06-14 2018-06-13 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 25 000 25 000
2018-06-14 2018-06-13 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 25 000 25 000
2018-06-14 2018-06-13 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 25 000 25 000
2018-06-14 2018-06-13 4 Campbell Bradley L PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 25 000 25 000
2018-06-14 2018-06-13 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 25 000 25 000
2018-03-02 3 Osorio Benedict PGNX Progenics Pharmaceuticals, Inc. Common Stock D 42 404
2018-03-02 3 Osorio Benedict PGNX Progenics Pharmaceuticals, Inc. Common Stock D 42 404
2018-03-02 2018-03-01 4 Osorio Benedict PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 100 000 100 000
2018-03-02 2018-03-01 4 Wong Vivien PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 94 875 94 875
2018-03-02 2018-03-01 4 Tenbarge Bryce PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 75 900 75 900
2018-03-02 2018-03-01 4 Summer Jeffery PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 94 875 94 875
2018-03-02 2018-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 201 250 201 250
2018-03-02 2018-03-01 4 Fabbio Patrick PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 94 875 94 875
2017-06-15 2017-06-14 4 Campbell Bradley L PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 20 000 20 000
2017-06-15 2017-06-14 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 20 000 20 000
2017-06-15 2017-06-14 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 20 000 20 000
2017-06-15 2017-06-14 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 20 000 20 000
2017-06-15 2017-06-14 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 55 000 55 000
2017-06-15 2017-06-14 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 20 000 20 000
2017-03-07 2017-03-01 4 Fabbio Patrick PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 11,32 82 500 82 500
2017-03-07 2017-03-01 4 Summer Jeffery PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 11,32 82 500 82 500
2017-03-07 2017-03-01 4 Tenbarge Bryce PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 11,32 66 000 66 000
2017-03-07 2017-03-01 4 Wong Vivien PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 11,32 82 500 82 500
2017-03-07 2017-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 11,32 175 000 175 000
2017-02-15 2017-02-15 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,5500 −150 000 −1 432 6 997 269
2017-02-15 2017-02-14 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,6800 −150 000 −1 452 7 147 269
2017-02-15 2017-02-14 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7000 −100 000 −970 7 297 269
2017-02-15 2017-02-14 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7000 −50 000 −485 7 397 269
2017-02-15 2017-02-14 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7000 −52 600 −510 7 447 269
2017-02-15 2017-02-13 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7000 −100 000 −970 7 499 869
2017-02-09 2017-02-09 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,6850 −1 300 −13 7 599 869
2017-02-09 2017-02-09 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,6600 −100 000 −966 7 601 169
2017-02-09 2017-02-09 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7500 −100 000 −975 7 701 169
2017-02-09 2017-02-07 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,6500 −50 000 −482 7 801 169
2017-02-09 2017-02-07 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7400 −100 000 −974 7 851 169
2017-01-13 2017-01-11 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock D - Sale to Issuer D 8,9500 −1 000 000 −8 950 7 951 169
2016-10-04 2016-10-03 4 Tenbarge Bryce PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,77 75 000 75 000
2016-08-25 3 Tenbarge Bryce PGNX Common Stock D 0
2016-06-09 2016-06-08 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 20 000 20 000
2016-06-09 2016-06-08 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 20 000 20 000
2016-06-09 2016-06-08 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 55 000 55 000
2016-06-09 2016-06-08 4 Campbell Bradley L PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 40 000 40 000
2016-06-09 2016-06-08 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 20 000 20 000
2016-06-09 2016-06-08 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 20 000 20 000
2016-04-22 2010-12-01 4/A MADDON PAUL J PGNX Common Stock P - Purchase D 4,9000 5 000 24 909 891
2016-03-03 2016-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,52 4,5200 175 000 791 175 000
2016-03-03 2016-03-01 4 Fabbio Patrick PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,52 4,5200 82 500 373 82 500
2016-03-03 2016-03-01 4 Hirt Sheldon PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,52 4,5200 82 500 373 82 500
2016-03-03 2016-03-01 4 Wong Vivien PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,52 4,5200 82 500 373 82 500
2015-12-03 2015-12-01 4 Fabbio Patrick PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,77 6,7700 125 000 846 125 000
2015-08-05 2015-08-03 4 Hirt Sheldon PGNX Non-Qualified Stock Option (right to buy) A - Award D 8,56 8,5600 125 000 1 070 125 000
2015-06-15 2015-06-11 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 6,8300 −2 000 −14 4 000
2015-06-15 2015-06-11 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,8300 −2 000 −14 35 050
2015-06-15 2015-06-11 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 2 000 11 37 050
2015-06-11 2015-06-10 4 Crowley Peter J PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 55 000 370 55 000
2015-06-11 2015-06-10 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 20 000 134 20 000
2015-06-11 2015-06-10 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 20 000 134 20 000
2015-06-11 2015-06-10 4 MADDON PAUL J PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 20 000 134 20 000
2015-06-11 2015-06-10 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 20 000 134 20 000
2015-06-11 2015-06-10 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 20 000 134 20 000
2015-04-01 3 Wong Vivien PGNX Common Stock D 8 242
2015-04-01 3 Wong Vivien PGNX Common Stock D 8 242
2015-03-16 2015-03-13 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,35 7,0000 −3 000 −21 15 000
2015-03-16 2015-03-13 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 7,0000 −3 000 −21 35 050
2015-03-16 2015-03-13 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3500 3 000 16 38 050
2015-03-13 2015-03-11 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 6,8300 −2 000 −14 6 000
2015-03-13 2015-03-11 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,8300 −2 000 −14 35 050
2015-03-13 2015-03-11 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 2 000 11 37 050
2015-03-04 2015-03-03 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 4,70 6,4900 −5 000 −32 61 000
2015-03-04 2015-03-03 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,4900 −5 000 −32 35 050
2015-03-04 2015-03-03 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 4,7000 5 000 24 40 050
2015-03-04 2015-03-02 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,65 6,6500 15 342 102 15 342
2015-03-04 2015-03-02 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,65 6,6500 66 000 439 66 000
2015-03-04 2015-03-02 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,65 6,6500 132 000 878 132 000
2015-03-04 2015-03-02 4 Lovallo Angelo William JR PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,65 6,6500 52 800 351 52 800
2015-01-13 2015-01-12 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 7,0560 −2 000 −14 8 000
2015-01-13 2015-01-12 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 7,0560 −2 000 −14 35 050
2015-01-13 2015-01-12 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 2 000 11 37 050
2014-12-12 2014-12-11 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,35 7,0670 −3 000 −21 18 000
2014-12-12 2014-12-11 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 7,0670 −3 000 −21 35 050
2014-12-12 2014-12-11 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3500 3 000 16 38 050
2014-11-21 2014-11-21 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,35 7,0000 −9 000 −63 21 000
2014-11-21 2014-11-21 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 7,0000 −9 000 −63 35 050
2014-11-21 2014-11-21 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3500 9 000 48 44 050
2014-11-14 2014-11-13 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 6,8300 −10 000 −68 10 000
2014-11-14 2014-11-13 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,8300 −10 000 −68 35 050
2014-11-14 2014-11-13 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 10 000 53 45 050
2014-11-12 2014-11-11 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,03 6,5300 −5 000 −33 55 000
2014-11-12 2014-11-11 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,5300 −5 000 −33 35 050
2014-11-12 2014-11-11 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,0300 5 000 25 40 050
2014-07-23 3 KOTLER KEVIN PGNX Common Stock D 14 651 466
2014-07-23 3 KOTLER KEVIN PGNX Common Stock D 14 651 466
2014-07-23 3 KOTLER KEVIN PGNX Common Stock D 14 651 466
2014-07-23 3 KOTLER KEVIN PGNX Common Stock D 14 651 466
2014-07-23 2014-07-21 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock P - Purchase D 4,7300 388 659 1 838 8 951 169
2014-07-23 2014-07-18 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock P - Purchase D 4,7300 388 200 1 836 8 562 510
2014-07-23 2014-07-17 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock P - Purchase D 4,4800 436 884 1 957 8 174 310
2014-07-23 2014-07-16 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock P - Purchase D 4,4800 411 693 1 844 7 737 426
2014-06-19 2014-06-17 4 Crowley Peter J PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 55 000 246 55 000
2014-06-19 2014-06-17 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 20 000 89 20 000
2014-06-19 2014-06-17 4 MADDON PAUL J PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 20 000 89 20 000
2014-06-19 2014-06-17 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 20 000 89 20 000
2014-06-19 2014-06-17 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 20 000 89 20 000
2014-06-19 2014-06-17 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 20 000 89 20 000
2014-03-04 2014-03-03 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,70 4,7000 132 000 620 132 000
2014-03-04 2014-03-03 4 Youssoufian Hagop PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,70 4,7000 66 000 310 66 000
2014-03-04 2014-03-03 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,70 4,7000 66 000 310 66 000
2014-03-04 2014-03-03 4 Lovallo Angelo William JR PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,70 4,7000 52 800 248 52 800
2014-01-30 2014-01-29 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,50 4,5000 40 000 180 40 000
2013-12-19 3/A Lovallo Angelo William JR PGNX Common Stock D 3 389
2013-09-12 2013-09-11 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (right to buy) A - Award D 5,91 5,9100 40 000 236 40 000
2013-08-08 2013-08-01 4 Youssoufian Hagop PGNX Non-Qualified Stock Option (right to buy) A - Award D 5,84 5,8400 150 000 876 150 000
2013-07-22 2013-07-18 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 6,3300 −5 000 −32 20 000
2013-07-22 2013-07-18 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,3300 −5 000 −32 35 050
2013-07-22 2013-07-18 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 5 000 27 40 050
2013-06-20 2013-06-12 4 Crowley Peter J PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,76 4,7600 55 000 262 55 000
2013-06-20 2013-06-12 4 GOFF STEPHEN P PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,76 4,7600 20 000 95 20 000
2013-06-20 2013-06-12 4 MADDON PAUL J PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,76 4,7600 20 000 95 20 000
2013-06-20 2013-06-12 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,76 4,7600 20 000 95 20 000
2013-06-20 2013-06-12 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,76 4,7600 20 000 95 20 000
2013-04-10 3 Lovallo Angelo William JR PGNX Common Stock D 2 945
2013-04-08 2013-04-04 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) A - Award D 5,03 5,0300 60 000 302 60 000
2013-04-08 2013-04-04 4 Olson William C PGNX Non-Qualified Stock Option (right to buy) A - Award D 5,03 5,0300 60 000 302 60 000
2013-04-08 2013-04-04 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 5,03 5,0300 120 000 604 120 000
2013-03-28 2013-03-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 5,3600 100 1 161 141
2013-03-28 2013-03-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 5,3400 50 0 161 041
2013-03-28 2013-03-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 5,3100 500 3 160 991
2013-03-22 2013-03-22 4 SCHEINBERG DAVID A PGNX Common Stock M - Exercise D 4,8090 −1 250 −6 46 185
2013-03-22 2013-03-22 4 SCHEINBERG DAVID A PGNX Common Stock M - Exercise D 2,4690 1 250 3 47 435
2013-03-21 2013-03-21 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 2,47 2,4690 1 250 3 1 250
2013-02-28 2013-02-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,7500 227 1 160 491
2013-02-28 2013-02-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,7200 535 1 160 264
2013-02-28 2013-02-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,7100 500 1 159 729
2013-01-23 2013-01-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,8300 315 1 159 229
2013-01-23 2013-01-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,8200 900 3 158 914
2012-12-26 2012-12-26 4 Baker Mark Robert PGNX Common Stock P - Purchase D 3,0100 1 142 3 158 014
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1400 7 0 156 872
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1300 1 000 2 156 865
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1300 100 0 155 865
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1260 100 0 155 765
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1200 100 0 155 665
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1200 300 1 155 565
2012-11-20 2012-11-19 4 Baker Mark Robert PGNX Common Stock P - Purchase D 1,9580 11 800 23 155 265
2012-11-19 2012-11-16 4 Baker Mark Robert PGNX Common Stock P - Purchase D 1,8220 49 793 91 143 465
2012-11-16 2012-11-15 4 Baker Mark Robert PGNX Common Stock P - Purchase D 1,6860 48 833 82 93 672
2012-10-25 2012-10-24 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,9550 1 162 3 44 839
2012-09-27 2012-09-26 4 Baker Mark Robert PGNX Common Stock P - Purchase D 3,3200 1 036 3 43 677
2012-08-23 2012-08-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 4,2340 815 3 42 641
2012-07-26 2012-07-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,0370 346 3 41 826
2012-07-03 2012-07-02 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 9,7900 −1 000 −10 25 000
2012-07-03 2012-07-02 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 9,7900 −1 000 −10 35 050
2012-07-03 2012-07-02 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1 000 5 36 050
2012-06-29 2012-06-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,2900 100 1 41 480
2012-06-29 2012-06-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,2900 179 2 41 380
2012-06-29 2012-06-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,2700 21 0 41 201
2012-06-29 2012-06-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,2100 75 1 41 180
2012-06-22 2012-06-20 4 Olson William C PGNX Common Stock D - Sale to Issuer D 8,6870 −1 230 −11 45 544
2012-06-22 2012-06-20 4 ISRAEL ROBERT J PGNX Common Stock D - Sale to Issuer D 8,5820 −3 333 −29 35 050
2012-06-14 2012-06-13 4 Crowley Peter J PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 40 000 317 40 000
2012-06-14 2012-06-13 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10 000 79 10 000
2012-06-14 2012-06-13 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10 000 79 10 000
2012-06-14 2012-06-13 4 GOFF STEPHEN P PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10 000 79 10 000
2012-06-14 2012-06-13 4 BRINER KURT W PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10 000 79 10 000
2012-06-14 2012-06-13 4 BAKER CHARLES A PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10 000 79 10 000
2012-06-14 2012-06-13 4 MADDON PAUL J PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10 000 79 10 000
2012-06-04 2012-06-01 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 8,5080 −1 000 −9 26 000
2012-06-04 2012-06-01 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 8,5080 −1 000 −9 38 383
2012-06-04 2012-06-01 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1 000 5 39 383
2012-05-24 2012-05-23 4 Baker Mark Robert PGNX Common Stock P - Purchase D 7,8100 445 3 41 105
2012-05-03 2012-05-01 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 10,9270 −1 000 −11 27 000
2012-05-03 2012-05-01 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 10,9270 −1 000 −11 38 383
2012-05-03 2012-05-01 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1 000 5 39 383
2012-04-27 2012-04-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,9200 100 1 40 660
2012-04-27 2012-04-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,9700 100 1 40 560
2012-04-27 2012-04-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,2500 15 0 40 460
2012-04-27 2012-04-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,2500 133 1 40 445
2012-04-03 2012-04-02 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 9,8520 −1 000 −10 28 000
2012-04-03 2012-04-02 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 9,8520 −1 000 −10 38 383
2012-04-03 2012-04-02 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1 000 5 39 383
2012-03-29 2012-03-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,1900 140 1 40 312
2012-03-29 2012-03-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,0000 100 1 40 172
2012-03-29 2012-03-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,1800 103 1 40 072
2012-03-05 2012-03-01 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) A - Award D 9,81 9,8100 50 000 490 50 000
2012-03-05 2012-03-01 4 Olson William C PGNX Non-Qualified Stock Option (right to buy) A - Award D 9,81 9,8100 50 000 490 50 000
2012-03-05 2012-03-01 4 MCKINNEY ROBERT A PGNX Non-Qualified Stock Option (right to buy) A - Award D 9,81 9,8100 50 000 490 50 000
2012-03-05 2012-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 9,81 9,8100 33 334 327 100 000
2012-03-05 2012-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 9,81 9,8100 66 666 654 66 666
2012-03-02 2012-03-01 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 9,8170 −1 000 −10 29 000
2012-03-02 2012-03-01 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 9,8170 −1 000 −10 38 383
2012-03-02 2012-03-01 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1 000 5 39 383
2012-02-27 2012-02-23 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 6,90 10,0000 −1 250 −12 0
2012-02-27 2012-02-23 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 6,90 6,9000 1 250 9 1 250
2012-02-27 2012-02-23 4 SCHEINBERG DAVID A PGNX Common Stock S - Sale D 10,0000 −1 250 −12 46 185
2012-02-27 2012-02-23 4 SCHEINBERG DAVID A PGNX Common Stock M - Exercise D 6,9000 1 250 9 47 435
2012-02-23 2012-02-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,5400 1 0 39 969
2012-02-23 2012-02-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4500 100 1 39 968
2012-02-23 2012-02-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4200 2 0 39 868
2012-02-23 2012-02-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4000 100 1 39 866
2012-02-23 2012-02-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4000 166 2 39 766
2012-02-03 2012-02-03 4 BRINER KURT W PGNX Common Stock S - Sale D 10,2190 −33 000 −337 0
2012-02-02 2012-02-01 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 9,4780 −1 000 −9 30 000
2012-02-02 2012-02-01 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 9,4780 −1 000 −9 38 383
2012-02-02 2012-02-01 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1 000 5 39 383
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,5600 100 1 39 600
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,5500 193 2 39 500
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,5000 4 0 39 307
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4900 3 0 39 303
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4500 1 0 39 300
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4500 63 1 39 299
2012-01-12 2012-01-11 4 Baker Mark Robert PGNX Common Stock P - Purchase D 8,8700 200 2 39 236
2012-01-12 2012-01-11 4 Baker Mark Robert PGNX Common Stock P - Purchase D 8,8600 191 2 39 036
2012-01-12 2011-10-26 4 Baker Mark Robert PGNX Common Stock P - Purchase D 6,5000 76 0 38 211
2012-01-12 2011-10-26 4 Baker Mark Robert PGNX Common Stock P - Purchase D 6,5200 455 3 38 135
2012-01-12 2011-10-26 4 Baker Mark Robert PGNX Common Stock P - Purchase D 6,5300 1 0 37 680
2012-01-04 2012-01-03 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 8,7800 −1 000 −9 31 000
2012-01-04 2012-01-03 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 8,7800 −1 000 −9 38 383
2012-01-04 2012-01-03 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1 000 5 39 383
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista